Lexicon Pharmaceuticals develops drug candidates and sells INPEFA, a heart failure treatment, from The Woodlands, Texas. It last closed at $1.53 on Nov 20, down 8.38% on the day. The next earnings report for LXRX is expected around Thu, Jan 28, 2027, after the close. For the quarter ended Sep 2026, LXRX reported EPS of -$0.03 on revenue of $11.3M, with revenue down 20.7% from a year ago. Over its last 8 reports the stock moved an average of 8.3% the session after earnings. Over the last 12 months LXRX insiders bought $2.8M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is LXRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LXRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on LXRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
LXRX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 7% below its 20 day and 13% below its 50 day average. It is 24% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 39). The nearest support is the Pivot S1 at $1.43, and the nearest resistance the Pivot at $1.57.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 7.5%/day
Key levels
$2.6852 week high+75.2%
$2.01100 day average+31.4%
$1.90200 day average+24.2%
$1.7350 day average+13.1%
$1.68Swing high (Oct 16)+9.8%
$1.66Pivot R1+8.5%
$1.6320 day average+6.5%
$1.57Pivot+2.6%
$1.53Last close
$1.43Pivot S1−6.5%
$1.38Swing low (Oct 30)−9.8%
$1.1052 week low−28.1%
Indicators
RSI (14)
38.74
Weak, oversold below 30
Neutral
MACD
0.00
Below its signal line
Bearish
Stochastic
40.8
Middle of its range
Neutral
ADX (14)
27.9
Trending down
Williams %R
-83.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-31.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.0%
Change over 10 sessions
Bearish
ATR (14)
$0.11
Typical daily range, 7.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityNormal, 18.2%/day
Key levels
$2.6852 week high+75.2%
$2.01100 day average+31.4%
$1.90200 day average+24.2%
$1.7350 day average+13.1%
$1.68Swing high (Oct 16)+9.8%
$1.66Pivot R1+8.5%
$1.6320 day average+6.5%
$1.57Pivot+2.6%
$1.53Last close
$1.43Pivot S1−6.5%
$1.38Swing low (Oct 30)−9.8%
$1.1052 week low−28.1%
Indicators
RSI (14)
41.10
Middle of its range
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
29.5
Middle of its range
Neutral
ADX (14)
26.7
Trending down
Williams %R
-85.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-90.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−23.5%
Change over 10 sessions
Bearish
ATR (14)
$0.28
Typical daily range, 18.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for LXRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LXRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow LXRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for LXRXHow many large options trades hit LXRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in LXRX in the last 90 days.
From SEC Form 4 filings by LXRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LXRX is in one of them and how their past LXRX trades turned out.
Lexicon Pharmaceuticals is a biopharmaceutical company based in The Woodlands, Texas. It markets INPEFA, a tablet taken once a day that is approved in the United States to lower the risk of cardiovascular death and heart failure hospitalization in adults with heart failure or related risk factors. Its drug candidates target hypertrophic cardiomyopathy, type 1 diabetes, and neuropathic pain, and it has licensed an obesity candidate to Novo Nordisk. INPEFA reaches patients through wholesalers, retail pharmacies, hospitals, and a mail order pharmacy, serving prescribers and patients.